Literature DB >> 30138766

Increased cortical beta power and spike-wave discharges in middle-aged APP/PS1 mice.

Nanxiang Jin1, Arto Lipponen1, Hennariikka Koivisto1, Kestutis Gurevicius1, Heikki Tanila2.   

Abstract

Amyloid plaque-forming transgenic mice display neuronal hyperexcitability, epilepsy, and sudden deaths in early adulthood. However, it is unknown whether hyperexcitability persists until middle ages when memory impairment manifests. We recorded multichannel video electroencephalography (EEG), local field potentials, and auditory evoked potentials in transgenic mice carrying mutated human amyloid precursor protein (APP) and presenilin-1 (PS1) genes and wild-type littermates at 14-16 months and compared the results with data we have earlier collected from 4-month-old mice. Furthermore, we monitored acoustic startle responses in other APP/PS1 and wild-type mice from 3 to 11 months of age. Independent of the age APP/PS1 mice demonstrated increased cortical power at 8-60 Hz. They also displayed over 5-fold increase in the occurrence of spike-wave discharges and augmented auditory evoked potentials compared with nontransgenic littermates. In contrast to evoked potentials, APP/PS1 mice showed normalization of acoustic startle responses with aging. Increased cortical power and spike-wave discharges provide powerful new biomarkers to monitor progression of amyloid pathology in preclinical intervention studies.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Amyloid plaque; EEG; Epilepsy; Transgenic

Mesh:

Substances:

Year:  2018        PMID: 30138766     DOI: 10.1016/j.neurobiolaging.2018.07.009

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  4 in total

1.  Chronic BACE-1 Inhibitor Administration in TASTPM Mice (APP KM670/671NL and PSEN1 M146V Mutation): An EEG Study.

Authors:  Susanna Lopez; Claudio Del Percio; Gianluigi Forloni; Angelisa Frasca; Wilhelmus H Drinkenburg; Roberta Lizio; Giuseppe Noce; Raffaele Ferri; Andrea Soricelli; Fabrizio Stocchi; Laura Vacca; Règis Bordet; Jill C Richardson; Claudio Babiloni
Journal:  Int J Mol Sci       Date:  2020-11-28       Impact factor: 5.923

2.  Preclinical evaluation of drug treatment options for sleep-related epileptiform spiking in Alzheimer's disease.

Authors:  Nanxiang Jin; Irina Gureviciene; Aysu Naz Atalay; Sara Häkli; Sofya Ziyatdinova; Heikki Tanila
Journal:  Alzheimers Dement (N Y)       Date:  2022-04-05

Review 3.  Amyloid-β: a potential link between epilepsy and cognitive decline.

Authors:  Michele Romoli; Arjune Sen; Lucilla Parnetti; Paolo Calabresi; Cinzia Costa
Journal:  Nat Rev Neurol       Date:  2021-06-11       Impact factor: 42.937

4.  Response of spike-wave discharges in aged APP/PS1 Alzheimer model mice to antiepileptic, metabolic and cholinergic drugs.

Authors:  Nanxiang Jin; Sofya Ziyatdinova; Irina Gureviciene; Heikki Tanila
Journal:  Sci Rep       Date:  2020-07-16       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.